The use of statins in optimising reduction of cardiovascular risk: Focus on fluvastatin

Research output: Contribution to journalArticlepeer-review

Abstract

Patients with widely differing degrees of cardiovascular risk can derive benefit from effective lipid-lowering therapy with statins, including patients with normal or low cholesterol levels. Clinical trials with fluvastatin have shown that it is effective in patients across a broad spectrum of cardiovascular risk. The lipid-lowering effects of fluvastatin are smaller than some statins, but major clinical outcome studies have consistently demonstrated morbidity and mortality benefits with reductions of low-density lipoprotein cholesterol of

Original languageEnglish
Pages (from-to)494-503
Number of pages10
JournalInternational Journal of Clinical Practice
Volume58
Issue number5
DOIs
Publication statusPublished - May 2004

Keywords

  • Adverse effects
  • Cardiovascular benefits
  • Drug interactions
  • HMG-CoA reductase inhibitors
  • Hypercholesterolaemia
  • Pleiotropic effects

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'The use of statins in optimising reduction of cardiovascular risk: Focus on fluvastatin'. Together they form a unique fingerprint.

Cite this